RoosterBio, based in Frederick, MD, specializes in accelerating the development of human mesenchymal stem cell (hMSC) and exosome products to enable scalable advanced therapies. The company drives rapid implementation of regenerative medicine solutions, positioning itself as a leader in scalable cell and exosome process development within the advanced therapy sector.

‌